Chen Y, He L, Ianevski A, Nader K, Ruokoranta T, Linnavirta N, Miettinen JJ, Vähä-Koskela M, Vänttinen I, Kuusanmaki H, Kontro M, Porkka K, Wennerberg K, Heckman CA, Giri AK, Aittokallio T(2025) A Machine Learning-Based Strategy Predicts Selective and Synergistic Drug Combinations for Relapsed Acute Myeloid Leukemia Cancer Res(in press) DOI 10.1158/0008-5472.CAN-24-3840, PubMed 40354625
Dechow A, Timonen S, Ianevski A, Jiang Q, Wahnschaffe L, Peng Y, Jungherz D, Becker K, Neubauer HA, Schönefeldt S, de Araujo E, Gunning P, Fleck R, Schrader A, Hallek M, Pflug N, Moriggl R, Aittokallio T, Mustjoki S, Braun T, Herling M(2025) Dual STAT3/STAT5 inhibition as a novel treatment strategy in T-prolymphocytic leukemia Leukemia(in press) DOI 10.1038/s41375-025-02577-8, PubMed 40234614
Tanoli Z, Fernández-Torras A, Özcan UO, Kushnir A, Nader KM, Gadiya Y, Fiorenza L, Ianevski A, Vähä-Koskela M, Miihkinen M, Seemab U, Leinonen H, Seashore-Ludlow B, Tampere M, Kalman A, Ballante F, Benfenati E, Saunders G, Potdar S, Gómez García I, García-Serna R, Talarico C, Beccari AR, Schaal W, Polo Aet al.(2025) Computational drug repurposing: approaches, evaluation of in silico resources and case studies Nat Rev Drug Discov(in press) DOI 10.1038/s41573-025-01164-x, PubMed 40102635
